DMI-Logo
search-iconsearch-icon

Neurology Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Neurology
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 July 27
Ataxia Market for Friedreich Ataxia, Spinocerebellar Ataxias, Gene Therapy and Rare-Neurology Care 2026-2035
The ataxia market reached US$ 2.38 billion in 2025 and is projected to reach US$ 6.71 billion by 2035, growing at 10.9% CAGR as Friedreich ataxia therapies, genetic testing, RNA treatments, protein replacement and gene therapy pipelines advance.
Starting from
$4350$3480
Published: 2026 July 27
Cholinergic Drugs Market for M1/M4 Antipsychotics, Dementia Therapy and Receptor-Targeted CNS Treatment 2026-2035
Cholinergic Drugs Market Outlook for Dementia, Schizophrenia and Muscarinic Therapies
Starting from
$4350$3480
Published: 2026 June 24
Addiction Treatment Market Size, Substance Use Disorder Trends and Forecast 2035
Explore the Addiction Treatment Market by opioid, alcohol, nicotine and substance use disorder treatment, MAT, rehab services, digital therapeutics and key players. Download a free sample or request an enquiry for detailed market insights.
Starting from
$4350$3480
Published: 2026 June 10
Neurotherapeutics Market Size, Neurological Drugs and Devices Forecast 2033
Explore the Neurotherapeutics Market by neurological drugs, neurostimulation devices, Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, end users and key players. Download a free sample or request an enquiry for detailed market insights.
Starting from
$4350$3480
Published: 2026 May 25
Anti-Amyloid Monoclonal Antibodies Market Size, Share Analysis, Growth Trends and Forecast 2026-2033
Anti-Amyloid Monoclonal Antibodies Market reached US$ 0.64 billion in 2025 and is expected to reach US$ 6.71 billion by 2033
Starting from
$4350$3480
Published: 2026 April 28
Alzheimer’s Disease Therapeutics Market Size, Share Analysis, Growth, Report 2026-2033
Alzheimer’s Disease Therapeutics Market to grow from USD 5.38B in 2025 to USD 17.98B by 2033 at 14.32% CAGR, driven by aging population and new therapies.
Starting from
$4350$3480
Published: 2026 June 19
Rare Neurological Disease Drugs Market Size, Share, Industry, Forecast and Outlook (2024-2031)
The Global Rare Neurological Disease Drugs Market is expected to reach at a CAGR of 8.6% during the forecast period 2024-2031.
Starting from
$4350$3480
Published: 2026 April 14
Epidural Abscess Treatment Market Size, Share, Industry, Forecast and outlook (2026-2033)
The global Epidural Abscess Treatment Market size was estimated at USD 52.65 billion in 2025, growing at a CAGR of 9.00% during (2026-2033).
Starting from
$4350$3480
Published: 2026 January 28
Gabapentin Market Size, Share, Growth, Forecast and Outlook (2024-2031)
Gabapentin Market overview covering market size, growth drivers, regional dynamics, competitive landscape, and long-term forecast insights.
Starting from
$4350$3480
Published: 2024 January 23
Refractory Status Drugs Epileptics Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Refractory Status Drugs Epileptics Market is expected to reach a CAGR of YY% By 2031 | DataM Intelligence
Starting from
$4350$3480